A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction

Conclusion: Anti-fibrotic therapy with FT011 in MI rats attenuated fibrosis and preserved systolic function.

Source: International Journal of Cardiology - December 10, 2012 Category: Cardiology Authors: Yuan Zhang, Maros Elsik, Amanda J. Edgley, Alison J. Cox, Andrew R. Kompa, Bing Wang, Christina Yan Ru Tan, Fay L. Khong, David I. Stapleton, Steven Zammit, Spencer J. Williams, Richard E. Gilbert, Henry Krum, Darren J. Kelly Tags: Original Articles Source Type: research